Marathon Capital Management’s The ExOne Company XONE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-10,000
Closed -$234K 232
2021
Q3
$234K Hold
10,000
0.05% 199
2021
Q2
$216K Hold
10,000
0.05% 177
2021
Q1
$313K Hold
10,000
0.08% 120
2020
Q4
$94K Hold
10,000
0.03% 153
2020
Q3
$122K Hold
10,000
0.04% 140
2020
Q2
$86K Hold
10,000
0.03% 132
2020
Q1
$63K Hold
10,000
0.03% 115
2019
Q4
$74K Hold
10,000
0.03% 137
2019
Q3
$89K Hold
10,000
0.04% 108
2019
Q2
$93K Hold
10,000
0.04% 106
2019
Q1
$84K Hold
10,000
0.04% 103
2018
Q4
$66K Hold
10,000
0.03% 101
2018
Q3
$94K Hold
10,000
0.04% 112
2018
Q2
$70K Hold
10,000
0.03% 109
2018
Q1
$72K Hold
10,000
0.03% 104
2017
Q4
$84K Hold
10,000
0.03% 101
2017
Q3
$114K Hold
10,000
0.05% 78
2017
Q2
$115K Hold
10,000
0.05% 79
2017
Q1
$102K Hold
10,000
0.05% 80
2016
Q4
$93K Hold
10,000
0.04% 77
2016
Q3
$152K Hold
10,000
0.08% 80
2016
Q2
$106K Buy
+10,000
New +$113K 0.05% 77
2014
Q3
Sell
-6,300
Closed -$250K 95
2014
Q2
$250K Buy
+6,300
New +$196K 0.2% 65

Marathon Capital Management's XONE Position: Q4 2021 in Review

Marathon Capital Management sold out of The ExOne Company (XONE) in Q4 2021, closing a stake of 10,000 shares — an estimated $234K sold.

Marathon Capital Management first reported a position in XONE in Q2 2014 and held it in 23 quarters. The position peaked at $313K in Q1 2021. 0 funds tracked by Wall St. Rank hold XONE as of Q4 2021.

  • Marathon Capital Management reported no remaining The ExOne Company position as of Q4 2021 after selling out during the quarter.
  • Marathon Capital Management sold 10,000 The ExOne Company shares in Q4 2021, an estimated $234K.
  • Marathon Capital Management first reported a position in The ExOne Company in Q2 2014 and held it in 23 quarters.
  • Marathon Capital Management's The ExOne Company position peaked at $313K in Q1 2021.
  • 0 funds tracked by Wall St. Rank held The ExOne Company as of Q4 2021.

Based on Marathon Capital Management's 13F filing for Q4 2021, filed 9 Feb 2022.